Inventor · disambiguated record
Richard Harrop
Also filed as: HARROP RICHARD
6 granted patents·9 pending applications·10 citations·filing 2003–2022
73Inventor score
Top patents by PatentIndex Score
15 records- 0182US7910109B2MHC class II epitopes of 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2003·Granted Mar 22, 2011·8 cites·5 claims
- 0275US7541044B2Administration of 5T4 antigen and immune response of cells expressing 5T4 and CEA antigensOXFORD BIOMEDICA LTD·Filed 2006·Granted Jun 2, 2009·2 cites·16 claims
- 0365US2023084645A1MethodOXFORD BIOMEDICA LTD·Filed 2022·Application pending·0 cites
- 0464US11427645B25T4-targeting agents and methodsOXFORD BIOMEDICA LTD·Filed 2018·Granted Aug 30, 2022·0 cites·34 claims
- 0553US2009191230A1CascadeOXFORD BIOMEDICA LTD·Filed 2006·Application pending·0 cites
- 0651US8133681B2Chemo-immunotherapy methodHARROP RICHARD·Filed 2008·Granted Mar 13, 2012·0 cites·5 claims
- 0749US2016231315A1FactorsOXFORD BIOMEDICA (UK) LTD·Filed 2016·Application pending·0 cites
- 0849US2016195554A1FactorsOXFORD BIOMEDICA LTD·Filed 2015·Application pending·0 cites
- 0946US2012213822A1Chemo-immunotherapy methodHARROP RICHARD·Filed 2012·Application pending·0 cites
- 1045US8147838B2PeptideHARROP RICHARD·Filed 2006·Granted Apr 3, 2012·0 cites·2 claims
- 1145US2012107862A1FactorsHARROP RICHARD·Filed 2011·Application pending·0 cites
- 1244US8642274B2Immunotherapeutic methodHARROP RICHARD·Filed 2009·Granted Feb 4, 2014·0 cites·8 claims
- 1342US2012039943A1FactorsHARROP RICHARD·Filed 2010·Application pending·0 cites
- 1442US2010158884A1CascadeOXFORD BIOMEDICA LTD·Filed 2010·Application pending·0 cites
- 1541US2013217116A1Peptide IICARROLL MILES·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →